View Press Releases
-
Symbiosis Appoints Joanne Anderson as Chief Commercial Officer
Mar 1, 2026
-
Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment
Feb 25, 2026
-
ELRIG Appoints Dr Kelly Gray and Dr Elaine Duncan to its Board
• Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery community • Drs Gray and Duncan to lead scientific programmes and early career initiatives, respectively
Feb 24, 2026
-
Epigenica AB Launches EpiFinder™ cNUC: The First Platform to Simultaneously Profile Multiple Histone Marks and DNA Methylation Directly from Circulating Nucleosomes in Plasma and Serum
Epigenica has announced the launch of EpiFinder™ cNUC, a unique product for liquid biopsies that significantly expands the capabilities of epigenomic research by delivering deep insights directly from circulating nucleosomes.
Feb 24, 2026
-
Healthcare Access Performance Leader BlockIt Rebrands as Alluvium Healthcare
Feb 23, 2026
-
Inceptua Group Appoints Healthcare Industry Leader Kurt Hilzinger as Chairman of the Board
Inceptua Group announces the appointment of Kurt J. Hilzinger as Chairman of the Board.
Feb 23, 2026
-
ClearNote Health’s Enhanced Avantect® Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance
ClearNote Health announced an enhanced Avantect® Pancreatic Cancer Test, which delivers a higher overall cancer detection sensitivity of 82.6% and specificity of 97.5% for patients at elevated risk of this disease.
Feb 22, 2026
-
Integrated DNA Technologies Unveils NGS Innovation Roadmap to Accelerate the Future of Cancer Research
IDT’s NGS roadmap reflects a multi-omics strategy built on differentiated chemistries and algorithms that support DNA, methylation, and RNA sequencing workflows.
Feb 22, 2026
-
Volta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026
Feb 22, 2026
-
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample
Feb 16, 2026
-
NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscia’s Platform
Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital pathology
Feb 16, 2026
-
Ambience Healthcare Expands “Chart Awareness” Across Its Intelligence Platform
Feb 11, 2026
-
Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization
Feb 8, 2026
-
SPT Labtech and BellBrook Labs Introduce High-Throughput Screening Platform for Cancer Research
Feb 8, 2026
-
Certara Introduces CRF Creator Module in Pinnacle 21® Enterprise Plus for Faster Clinical Study Start-Up in Drug Development
New module streamlines standardized CRF (case report form) design and EDC build to help clinical teams start studies faster.
Feb 5, 2026
-
Innovate UK awards over £300k SMART grant to Exeter HealthTech Research Centre and Sanome to advance AI-enabled early detection of hospital-acquired infections
Feb 8, 2026
-
Firstsource and Prosper AI Partner to Advance Healthcare Revenue Cycle Management with Next-Level Voice AI Capabilities
Feb 4, 2026
-
Ambience Healthcare Partners with MultiCare Health System on Enterprise Rollout of AI Platform
Feb 2, 2026
-
Cirena Launches High-Purity Long RNA to Accelerate CRISPR and Genome-Editing Research
Cirena has announced its public launch following successful delivery of high-quality long RNA to leading academic and pharmaceutical research teams across the U.S., Europe, and Japan.
Feb 2, 2026
-
Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica
Jan 29, 2026


